Schedule

9:00-10:00: How to investigate the hallmarks of aging: From bench to bedside [Jeremy Michael Van Raamsdonk - McGill University (Canada), Chantal Autexier - McGill University (Canada), Louis R. Lapierre - Université de Moncton (Canada), Michael Kobor - University of British Columbia (Canada)] 10:00-11:00: How to design my geroscience clinical trial? [Perry Kim - Queen’s University (Canada), Mohammad Auais - Queen’s University (Canada), George Kuchel - University of Connecticut (USA), James Kirkland - Mayo Clinic (USA), John Muscedere - Queen’s University (Canada)] 11:00-11:15: Coffee break - networking 11:15-12:15: Bringing my discovery to real life: IP, commercialization, implementation [Louise Pilote - McGill University (Canada), Guy Hajj-Boutros - McGill University (Canada), Ann Beliën - Rejuvenate Biomed (Belgium)]

George Sutphin, University of Arizona (USA) - Targeting kynurenine metabolism in aging and age-associated disease Lea Harrington, University of Toronto (Canada) - CRISPR-based screens to illuminate the genetic landscape in response to the senotherapeutic compounds resveratrol and pterostilbene